Kiniksa Pharmaceuticals International, plc
5 clinical trials · Sponsor
◉ Watch Kiniksa Pharmaceuticals International, plc
| Record | Firm | Date |
|---|---|---|
| Transition to KPL-387 Monotherapy Dosing & Administration Study (NCT07288216) | Kiniksa Pharmaceuticals International, plc | 2026-03-25 |
| Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387 (NCT07010159) | Kiniksa Pharmaceuticals International, plc | 2025-07-25 |
| A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease (NCT06531395) | Kiniksa Pharmaceuticals International, plc | 2024-07-17 |
| REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients (NCT04687358) | Kiniksa Pharmaceuticals International, plc | 2021-03-16 |
| Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation (NCT04447469) | Kiniksa Pharmaceuticals International, plc | 2020-07-28 |
Track Kiniksa Pharmaceuticals International, plc automatically
Every clearance here is in the API, with alerts when new ones post.